- Home
- CBLL
CBLL
CeriBell Inc.
as of 09-23-2026 4:00pm EST
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
| Founded: | 2014 | Country: | United States |
| Employees: | 300 | City: | SUNNYVALE |
| Market Cap: | 935.3M | IPO Year: | 2024 |
| Target Price: | $23.20 | AVG Volume (30 days): | 269.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.03 | EPS Growth: | 56.93 |
| 52 Week Low/High: | $10.85 - $25.63 | Next Earning Date: | 05-11-2026 |
| Revenue: | $89,063,000 | Revenue Growth: | 36.09% |
| Revenue Growth (this year): | 29.57% | Revenue Growth (next year): | 28.44% |
| P/E Ratio: | -23.54 | Index: | N/A |
| Free Cash Flow: | -41575000.0 | FCF Growth: | N/A |
AI-Powered CBLL Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of CeriBell Inc. (CBLL)
President and CEO
Avg Cost/Share
$25.03
Shares
20,846
Total Value
$521,775.38
Owned After
746,345
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$25.00
Shares
846
Total Value
$21,150.00
Owned After
146,600
SEC Form 4
Senior VP, Finance and PAO
Avg Cost/Share
$24.26
Shares
9,255
Total Value
$224,451.30
Owned After
34,144
Chief Technology Officer
Avg Cost/Share
$24.33
Shares
4,887
Total Value
$118,900.71
Owned After
203,118
SEC Form 4
President and CEO
Avg Cost/Share
$24.61
Shares
39,540
Total Value
$973,079.40
Owned After
746,345
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$25.00
Shares
652
Total Value
$16,300.00
Owned After
146,600
SEC Form 4
Senior VP, Finance and PAO
Avg Cost/Share
$23.95
Shares
859
Total Value
$20,573.05
Owned After
34,144
SEC Form 4
President and CEO
Avg Cost/Share
$24.02
Shares
6,068
Total Value
$145,753.36
Owned After
746,345
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$24.02
Shares
1,521
Total Value
$36,534.42
Owned After
146,600
SEC Form 4
Chief Revenue Officer
Avg Cost/Share
$24.02
Shares
1,361
Total Value
$32,691.22
Owned After
55,956
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Chao Xingjuan | CBLL | President and CEO | Sep 15, 2026 | Sell | $25.03 | 20,846 | $521,775.38 | 746,345 | |
| Blumberg Scott | CBLL | Chief Financial Officer | Sep 15, 2026 | Sell | $25.00 | 846 | $21,150.00 | 146,600 | |
| Foehr David | CBLL | Senior VP, Finance and PAO | Sep 8, 2026 | Sell | $24.26 | 9,255 | $224,451.30 | 34,144 | |
| Woo Raymond | CBLL | Chief Technology Officer | Sep 8, 2026 | Sell | $24.33 | 4,887 | $118,900.71 | 203,118 | |
| Chao Xingjuan | CBLL | President and CEO | Sep 2, 2026 | Sell | $24.61 | 39,540 | $973,079.40 | 746,345 | |
| Blumberg Scott | CBLL | Chief Financial Officer | Sep 2, 2026 | Sell | $25.00 | 652 | $16,300.00 | 146,600 | |
| Foehr David | CBLL | Senior VP, Finance and PAO | Aug 24, 2026 | Sell | $23.95 | 859 | $20,573.05 | 34,144 | |
| Chao Xingjuan | CBLL | President and CEO | Aug 21, 2026 | Sell | $24.02 | 6,068 | $145,753.36 | 746,345 | |
| Blumberg Scott | CBLL | Chief Financial Officer | Aug 21, 2026 | Sell | $24.02 | 1,521 | $36,534.42 | 146,600 | |
| Manni Joseph S. | CBLL | Chief Revenue Officer | Aug 21, 2026 | Sell | $24.02 | 1,361 | $32,691.22 | 55,956 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Aug 10, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLAug 10, 2026 · 100% conf.
1D
-7.97%
$17.76
Act: +10.41%
5D
-14.07%
$16.58
20D
-10.87%
$17.20
Transcript text not available. View on SEC.gov →
2026 Q1 Q1 2026 Earnings
8-K May 11, 2026
Q1 2026 Earnings
8-KMay 11, 2026
2025 Q4 Q4 2025 Earnings
8-K Feb 24, 2026
Q4 2025 Earnings
8-KFeb 24, 2026
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
Q3 2025 Earnings
8-KNov 4, 2025
2025 Q2 Q2 2025 Earnings
8-K Aug 5, 2025
Q2 2025 Earnings
8-KAug 5, 2025
2025 Q1 Q1 2025 Earnings
8-K May 8, 2025
Q1 2025 Earnings
8-KMay 8, 2025
2024 Q4 Q4 2024 Earnings
8-K Feb 25, 2025
Q4 2024 Earnings
8-KFeb 25, 2025
2024 Q3 Q3 2024 Earnings
8-K Nov 12, 2024
Q3 2024 Earnings
8-KNov 12, 2024
Compare CBLL vs Leading Stocks
See how CBLL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CBLL CeriBell Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.